Goodwill and Intangible Assets (Tables)

12 Months Ended

Sep. 30, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

The changes in the carrying amount of goodwill by segment were as follows:



	September 30, 2016		September 25, 2015
Specialty Brands	$	3,498.3	$	3,442.4
Specialty Generics	207.0		207.0
Total	$	3,705.3	$	3,649.4

During the fiscal year ended September 30, 2016, the gross carrying value of goodwill in the Specialty Brands segment increased by $55.9 million, primarily attributable to $57.3 million from the Stratatech Acquisition. The remaining change in goodwill is a result of the Hemostasis Acquisition, offset by purchase accounting adjustments for the Therakos Acquisition and Ikaria Acquisition primarily attributable to changes in deferred tax balances.

Schedule of Intangible Assets

The gross carrying amount and accumulated amortization of intangible assets, excluding held for sale intangible assets, at the end of each period were as follows:



	September 30, 2016				September 25, 2015
	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Amortizable:
Completed technology	$	10,028.8	$	1,446.2	$	9,896.0	$	765.8
Licenses	185.1		112.3		185.1		99.8
Customer relationships	28.6		8.0		28.1		4.4
Trademarks	82.2		10.0		82.1		6.2
Other	6.7		6.7		6.7		6.7
Total	$	10,331.4	$	1,583.2	$	10,198.0	$	882.9
Non-Amortizable:
Trademarks	$	35.0			$	35.0
In-process research and development	399.1				316.2
Total	$	434.1			$	351.2

Schedule of Future Amortization Expense, Intangible Assets

The estimated aggregate amortization expense on intangible assets owned by the Company, excluding held for sale intangible assets, is expected to be as follows:




Fiscal 2017	$	701.4
Fiscal 2018	692.4
Fiscal 2019	692.1
Fiscal 2020	691.9
Fiscal 2021	691.6